TGF-Beta Signaling in Catagen Induction How Follicle Regr…

Understanding the Catagen Phase and Why It Matters

The hair growth cycle consists of three phases: anagen (growth), catagen (regression), and telogen (rest). While most hair loss research focuses on why follicles fail to re-enter anagen, an equally important question is: what actively pushes them into catagen? The answer centers on Transforming Growth Factor-Beta (TGF-β) signaling — one of the most powerful catagen-inducing pathways in human biology.

TGF-Beta Signaling in Catagen Induction How Follicle Regression Starts

TGF-β1 and TGF-β2 are the primary isoforms involved in hair follicle regulation. A 2000 study by Foitzik and colleagues, published in the FASEB Journal, demonstrated that TGF-β1 injection into mouse skin prematurely induced catagen, while blocking TGF-β signaling delayed catagen onset. This was among the first direct evidence that TGF-β is not merely correlated with catagen — it causes it.

The Molecular Mechanism: How TGF-β Triggers Follicle Regression

TGF-β signaling begins when TGF-β ligands bind to the type II receptor (TβRII), which then recruits and phosphorylates the type I receptor (TβRI, also called ALK5). This activated receptor complex phosphorylates Smad2 and Smad3 proteins, which form a complex with Smad4 and translocate to the nucleus to regulate gene expression.

In the hair follicle, this cascade produces several catagen-promoting effects:

1. Apoptosis of Hair Matrix Keratinocytes

TGF-β1 directly induces apoptosis (programmed cell death) in the rapidly dividing keratinocytes of the hair matrix. It upregulates pro-apoptotic genes including Bax and caspase-3 while downregulating anti-apoptotic Bcl-2. This is the primary mechanism by which the hair shaft production ceases.

2. Extracellular Matrix Remodeling

TGF-β stimulates the production of matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, which degrade the extracellular matrix surrounding the hair bulb. This remodeling physically disconnects the dermal papilla from the hair matrix, a defining event of catagen.

3. Suppression of Proliferative Signals

TGF-β antagonizes Wnt/β-catenin signaling — the pathway most critical for anagen maintenance. By upregulating Wnt inhibitors such as DKK1, TGF-β creates a molecular environment hostile to hair growth.

4. Epithelial-Mesenchymal Transition (EMT)

TGF-β promotes EMT in follicle epithelial cells, changing their phenotype from proliferative to migratory. This contributes to the formation of the epithelial strand that characterizes the catagen follicle.

The DHT-TGF-β Connection

This is where TGF-β signaling intersects with the most well-known driver of pattern hair loss. Dihydrotestosterone (DHT) upregulates TGF-β1 and TGF-β2 expression in dermal papilla cells. A 2006 study in the Journal of Dermatological Science showed that DHT-treated dermal papilla cells produced significantly more TGF-β1, which in turn suppressed proliferation of neighboring keratinocytes.

This creates a cascade: DHT → TGF-β upregulation → catagen induction → follicle miniaturization. It explains why anti-androgens like finasteride work partly by reducing TGF-β output, not just by lowering DHT directly.

TGF-β Isoforms and Their Distinct Roles

TGF-β1: The primary catagen inducer. Strongly upregulated by DHT. Most abundant isoform in balding scalp.
TGF-β2: Also promotes catagen but plays additional roles in follicle development and pigmentation regulation.
TGF-β3: Interestingly, TGF-β3 may have anti-fibrotic properties and could counteract some effects of TGF-β1. This isoform is being investigated for its potential to prevent scarring alopecia.

Therapeutic Approaches Targeting TGF-β

Natural TGF-β Inhibitors

Several natural compounds have demonstrated TGF-β inhibitory activity in preclinical studies:

Curcumin: Downregulates TGF-β1 expression and Smad signaling. Topical curcumin formulations show promise in reducing catagen progression in animal models.
Green tea polyphenols (EGCG): Shown to inhibit TGF-β1 production in dermal papilla cells and protect against DHT-induced growth suppression.
Resveratrol: Reduces TGF-β-mediated fibrosis and may help maintain anagen duration.

Pharmacological Approaches

Smad7 overexpression: In animal models, forced expression of Smad7 (an inhibitory Smad that blocks TGF-β signaling) delays catagen and extends anagen. Gene therapy approaches using this target are in early development.
TGF-β neutralizing antibodies: While used in fibrosis research, topical application for hair loss has not been clinically tested.
ALK5 inhibitors: Small molecule inhibitors of the TGF-β type I receptor could theoretically block catagen induction, but systemic toxicity concerns limit their use.

Existing Treatments and TGF-β

Minoxidil partially counteracts TGF-β by upregulating VEGF and promoting survival signals in follicle keratinocytes. Finasteride reduces TGF-β output by lowering DHT. Neither directly blocks TGF-β, which may explain why some patients see incomplete results — the catagen signal is reduced but not eliminated.

Practical Implications

Catagen is an active process, not passive degeneration — TGF-β actively drives follicle regression, and reducing this signal is as important as promoting anagen.
DHT works partly through TGF-β — understanding this cascade explains why anti-androgens and growth promoters have complementary effects.
Anti-inflammatory and anti-fibrotic strategies may help — since TGF-β is both pro-inflammatory and pro-fibrotic, reducing chronic scalp inflammation may lower TGF-β levels.
Natural TGF-β inhibitors are accessible but not potent enough alone — curcumin, EGCG, and resveratrol can complement but not replace established treatments.
Future combination therapies that address both Wnt activation and TGF-β inhibition simultaneously may prove more effective than current approaches.

The TGF-β pathway reminds us that hair loss is a push-pull system: follicles need both the absence of inhibitory signals (TGF-β, PGD2, DKK1) and the presence of stimulatory signals (Wnt, VEGF, FGF) to sustain anagen. Addressing only one side of this equation leaves the other unchecked.

TGF-Beta Isoform Balance and Therapeutic Precision

The three TGF-β isoforms have different and sometimes opposing effects on hair follicles, creating opportunities for precision therapy. TGF-β1 is the primary catagen promoter and is the isoform most elevated in balding scalp. TGF-β2 shares catagen-promoting activity but also regulates follicle pigmentation. TGF-β3, however, has anti-fibrotic properties and may actually protect against the perifollicular fibrosis that impairs follicle regeneration.

This isoform specificity means that broad-spectrum TGF-β inhibition could be counterproductive — blocking TGF-β3 while trying to inhibit TGF-β1 would remove an anti-fibrotic signal. The ideal therapeutic approach would selectively inhibit TGF-β1 and TGF-β2 while preserving or enhancing TGF-β3 activity.

This precision is challenging to achieve with small molecules but may be possible with isoform-specific neutralizing antibodies. Several biotech companies have developed TGF-β isoform-specific antibodies for cancer fibrosis applications, and these could potentially be adapted for topical scalp use.

Also, the timing of TGF-β inhibition matters. During catagen, some TGF-β activity is necessary for orderly follicle regression. Completely blocking TGF-β during catagen could produce disorganized follicle structures that are unable to properly re-enter anagen. The most promising approach may be reducing excessive TGF-β1 during early anagen — when the follicle needs to sustain growth — rather than blocking it entirely throughout the cycle.

TGF-Beta and the Fibrosis Connection in Long-Standing Baldness

One of the most consequential effects of chronic TGF-β1 elevation in balding scalp is perifollicular fibrosis — the deposition of dense collagen bundles around follicles that eventually replaces the normal loose connective tissue. This fibrosis has been documented histologically in advanced androgenetic alopecia, where the perifollicular dermis shows increased collagen type I deposition and reduced elastin content. Importantly, this fibrotic tissue is not merely a passive structural change — it actively impairs follicle regeneration through several mechanisms. First, the dense collagen matrix physically constrains the downward growth of the follicle during anagen, preventing full-length hair production. Second, fibrotic tissue has reduced vascularity, limiting nutrient supply to the follicle. Third, fibroblasts in fibrotic tissue produce more TGF-β1, creating a self-reinforcing cycle of fibrosis and TGF-β elevation. This fibrotic component of balding explains why very advanced hair loss is difficult to reverse even with treatments that successfully address the hormonal and vascular aspects of the condition.

Natural Compounds That Modulate TGF-Beta

Several natural compounds have demonstrated TGF-β modulating activity in preclinical studies. Curcumin, the active component of turmeric, inhibits TGF-β1 signaling by blocking Smad2/3 phosphorylation at concentrations achievable through oral supplementation. A 2018 study demonstrated that curcumin supplementation reduced TGF-β1 levels in scalp tissue of mice with DHT-induced hair follicle regression. Resveratrol, found in grapes and Japanese knotweed, reduces TGF-β1 transcription through SIRT1-mediated suppression of the TGF-β1 promoter. Green tea catechins, particularly epigallocatechin-3-gallate (EGCG), inhibit TGF-β1 signaling through multiple mechanisms including Smad7 upregulation. While these natural compounds are far less potent than pharmaceutical TGF-β inhibitors, their excellent safety profiles make them suitable for long-term complementary use alongside standard hair loss treatments.

TGF-Beta and the Hair Follicle Pigment Unit

TGF-β2 has a specific role in regulating the hair follicle pigment unit — the melanocytes and keratinocytes that produce hair color. During catagen, TGF-β2 promotes melanocyte apoptosis and the transfer of melanin to the follicle epithelium, contributing to the depigmentation of the catagen club hair. This TGF-β2-mediated melanocyte loss is one reason why regrown hairs after telogen are sometimes lighter than the original hair — the pigment unit may not fully recover from the TGF-β2-driven apoptosis of catagen.

TGF-Beta Signaling in Catagen Induction How Follicle Regression Starts